Diabetic Foot News and Research

RSS

Bioinformatics expert receives $12.8 million grant to continue to lead Diabetic Complications Consortium

Dr. Richard A. McIndoe, bioinformatics expert and associate director of the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia at Augusta University, has received a $12.8 million grant to continue to lead a national research initiative focused on reducing the complications of diabetes.

26 Aug 2017

When wounds won’t heal, therapies spread — to the tune of $5 billion

Carol Emanuele beat cancer. But for the past two years, she has been fighting her toughest battle yet. She has an open wound on the bottom of her foot that leaves her unable to walk and prone to deadly infection.

3 Aug 2017

Mitochondria-targeted antioxidant shows promise for diabetic wound treatment

Members of the Faculty of Biology and A.N. Belozersky Institute of Physico-Chemical Biology, a unit of the Lomonosov Moscow State University, have tested on a mouse model a mitochondria-targeted antioxidant, helping to treat diabetic wounds.

29 Jun 2017

Study helps healthcare professionals to select appropriate material for prescription footwear

There isn't a one-size-fits-all approach when choosing the right footwear or inner sole to take away pressure from diabetic patients' feet. The body mass index (BMI) of diabetics indicates how stiff or soft the cushioning material in shoes should be.

16 May 2017

FDA-approved, bioengineered living-cell therapy can shift genomic profile of non-healing wounds

Apligraf - an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. - has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a treated non-healing wound, according to new research published in the peer-reviewed journal Science Translational Medicine.

6 Jan 2017

QUT study explores burden of foot disease on Australian health system

The "silent burden" of foot disease afflicts one in ten hospital patients, costing taxpayers billions and filling nearly 5,000 hospital beds each night, according to QUT research.

15 Nov 2016

Better treatment for diabetic foot disease could save billions for Australia, finds QUT research

Australia could save billions of dollars in healthcare costs by investing in proven treatments for people with diabetic foot disease, according to QUT research.

20 Oct 2016

Fungal communities in chronic wounds can be linked to poor outcomes and slow healing

Researchers in Pennsylvania and Iowa have discovered that fungal communities found in chronic wounds can form mixed bacterial-fungal biofilms and can be associated with poor outcomes and longer healing times.

6 Sep 2016

Solution made of silver nanoparticles shows promise in healing diabetic foot ulcers

One of the major complications of diabetes is the appearance of wounds in the lower extremities that do not heal properly.

31 Aug 2016

Transplantation of placenta-derived MSCs can prevent diabetes-related CLI in rats

In an effort to determine if stem cell therapy can prevent or improve a condition called "diabetic foot" caused by poor blood flow in patients with diabetes, a team of researchers in China has found that transplanting human placenta-derived mesenchymal stem cells (MSCs) into rats modeled with diabetes can affect blood vessel growth, potentially improving blood flow and preventing critical limb ischemia (CLI), a condition that results in diabetic foot and frequently leads to amputation.

30 Aug 2016

Researchers reprogram skin cells from diabetic foot ulcers to generate iPSCs

The potential to use a patient's own cells to treat non-healing chronic wounds - a serious complication of diabetes - took an important step forward as researchers successfully reprogrammed skin cells taken from diabetic foot ulcers to form induced pluripotent stem cells (iPSCs).

10 Aug 2016

Preventable hospitalisation from diabetic foot disease costing Australia millions of dollars

New research from QUT shows preventable hospitalisation from diabetic foot disease is costing Australia hundreds of millions of dollars each year.

20 Jul 2016

New topical film patch can effectively close dermal wounds, reduce scarring

Currently there is no product available based on polymer film containing active molecules to accelerate dermal wound healing that also reduces the scar formation.

8 Jul 2016

IQWiG study: HBOT shows neither hint of benefit nor of harm in people with diabetic foot

If people with a diabetic foot syndrome (DFS) receive hyperbaric oxygen therapy (HBOT) in addition to conventional treatment, this can promote wound healing. However, the certainty of conclusions of the available study results is restricted.

6 Jul 2016

NR supplements can reduce diabetes-related complications in mice

A naturally occurring vitamin, nicotinamide riboside (NR), can lower blood sugar levels, reduce fatty liver, and prevent peripheral nerve damage in mouse models of prediabetes and type 2 diabetes (T2D), according to a new study by researchers at the University of Iowa and the Iowa City VA Health Care System.

27 May 2016

Texas to host first-ever delegation of UK’s medical technology companies

Texas is about to play host to the first ever delegation of innovative medical technology companies from the United Kingdom.

From Paxman 13 May 2016

Researchers develop insoles impregnated with silver nanoparticles to treat diabetic foot syndrome

Scientists from Tomsk Polytechnic University and National Autonomous Mexico University develop techniques to treat diabetic foot syndrome with special insoles with silver nano-particles. The techniques help to fight ulcers appearing on feet in diabetic patients, facilitates their healing and disinfection, reducing the risk of amputation.

20 Apr 2016

Tecnalia's transparent bioadjesive gel could treat diabetic foot ulcers

Tecnalia's Pharmaceutical Development laboratory conducts the selection of the candidate polymers and topical antiseptics necessary to obtain a stable, safe and effective formula in the form of a transparent bioadjesive gel specific for the treatment of diabetic foot ulcers.

19 Apr 2016

Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

The U.S. Food and Drug Administration today approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. The matrix device, which is made of silicone, cow collagen, and shark cartilage, is placed over the ulcer and provides an environment for new skin and tissue to regenerate and heal the wound.

7 Jan 2016

Drexel biomedical engineer identifies immune cell as potential strategy for growing blood vessels

In what could be a pivotal step toward repairing non-healing wounds and damaged organs, a Drexel University biomedical engineer has identified an immune cell as a potential strategy for growing blood vessels.